Cancer Protein Description
This report provides a detailed description of a selected cancer protein with information collected from various sources, including UniProt, the Wellcome Trust Sanger Institute’s Catalogue of Somatic Mutations in Cancer (COSMIC), and the Atlas of Genetics and Cytogenetics in Oncology and Haematology.
| Protein Name: | DVL3 |
| Gene Name: | DVL3 |
| Protein Full Name: | Segment polarity protein dishevelled homolog DVL-3 |
| Alias: | Dishevelled 3; Dishevelled-3; DSH 3; DSH-3; Segment polarity protein dishevelled DVL-3 |
| Mass (Da): | 78055 |
| Number AA: | 716 |
| UniProt ID: | Q92997 |
| Locus ID: | 1857 |
| COSMIC ID: | DVL3 |
| Gene location on chromosome: | 3q27 |
| Cancer protein type: | OP |
| Effect of cancer mutation on protein: | GAIN |
| Effect of active protein on cancer: | PROMOTES |
| Number of cancer specimens: | 20237 |
| Percent of cancer specimens with mutations: | 0.63 |
| Normal role description: | DVL3 is a cytoplasmic protein involved in wnt signalling. It is a phosphoprotein that regulates cell proliferation. Its over expression is correlated with increased cell proliferation in cancer. |